If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
71.60    1.00 (1.42%)
Bid:
71.50
Ask:
71.80
Spread: 0.30 (0.42%)
Market Cap: £183.83m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Update

19 Mar 2024 07:00

RNS Number : 3177H
Crest Nicholson Holdings PLC
19 March 2024
 

 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018

Crest Nicholson Holdings plc

 (the 'Group' or 'Crest Nicholson')

 

AGM

Crest Nicholson Holdings plc is holding its Annual General Meeting ('AGM') at 11:00 am today at the Group's Head Office: 500 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey KT15 2HJ. This trading update is for the period from 1 November 2023 to 15 March 2024. The Company's FY24 year end is on 31 October 2024.

Current trading

The Group has achieved reservations in line with expectations and delivered a year-to-date open market SPOW rate of 0.44, based on 46 outlets, with reduced activity before Christmas and a stronger performance from mid-January. The SPOW rate for the last eight weeks to 15 March 2024 improved to 0.52. Sale prices achieved have been in line with expectations and cancellations remained at normalised levels. Build activity in the sector continued to operate at a lower level which is now resulting in lower labour costs in some areas. Overall build cost inflation has largely stabilised and at a level lower than prior year.

The Group remains focused on improving customer service and since February 2023 has consistently achieved >90% customer satisfaction rating.

The planning system continues to be challenging. Our strong land portfolio with several quality sites acquired last year places us in a favourable position to mitigate planning delays and support future outlet growth.

Farnham and other legacy sites

Construction at the Farnham development and other legacy sites which are still being completed is progressing largely as planned.

Pre 2019 completed sites

Since the publication of the FY23 results, the Group has become aware of certain build defects predominantly on four sites that were completed prior to 2019 when the Group closed its Regeneration and London divisions. These sites will require remediation over the next three years at an estimated cost of up to £15m. As a result, the Board has decided to appoint third party consultants to provide greater assurance on the adequacy of current provisions around these and other sites completed prior to 2019. A further update will be provided at the Group's interim results in June.

Outlook

The Group continues to focus on optimising value and expects FY24 completions to be in the range of 1,800 to 2,000 homes, with completions weighted approximately 35/65% in favour of the second half of the year, reflecting the opening order book and the low level of reservations in the first two months of the financial year. Sales prices are expected to remain stable in FY24. Net debt at the end of February 2024 is tracking lower than expected as a result of lower build and land spend and this trend is expected to continue in the remainder of the financial year.

The person responsible for arranging the release of this announcement on behalf of the Company is Penny Thomas, Group Company Secretary.

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo

James Macey White / Giles Kernick +44 (0) 207 260 2700

19 March 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTVSITLIS
Date   Source Headline
14th Jun 20247:00 amRNSResponse to Announcement by Bellway p.l.c.
13th Jun 20247:15 amRNSDirectorate Change
13th Jun 20247:00 amRNSHalf-year Report
6th Jun 20242:19 pmRNSHolding(s) in Company
30th May 202410:44 amRNSHolding(s) in Company
30th Apr 202410:40 amRNSHolding(s) in Company
26th Apr 20243:06 pmRNSHolding(s) in Company
25th Apr 20244:45 pmRNSHolding(s) in Company
17th Apr 202410:25 amRNSBlock listing Interim Review
11th Apr 20244:53 pmRNSHolding(s) in Company
8th Apr 20244:02 pmRNSDirectorate Change
21st Mar 202411:49 amRNSHolding(s) in Company
20th Mar 20244:42 pmRNSHolding(s) in Company
19th Mar 20241:20 pmRNSResult of AGM
19th Mar 20247:00 amRNSTrading Update
7th Mar 202410:36 amRNSDirector Declaration
21st Feb 20241:13 pmRNSHolding(s) in Company
13th Feb 202411:10 amRNSAnnual Report and Notice of AGM
6th Feb 202411:51 amRNSDirector/PDMR Shareholding
6th Feb 202411:22 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSDirectorate Change
23rd Jan 20247:00 amRNSFinal Results
15th Jan 20247:00 amRNSFY23 Trading Update
10th Jan 20244:30 pmRNSHolding(s) in Company
10th Jan 20244:30 pmRNSHolding(s) in Company
24th Nov 202311:00 amRNSDirectorate Change
16th Nov 20237:00 amRNSTrading Statement
13th Nov 202310:00 amRNSDirectorate Change
3rd Nov 202310:03 amRNSDirectorate Change
17th Oct 202310:00 amRNSBlock listing Interim Review
13th Oct 20237:00 amRNSDirectorate Change
18th Sep 20234:16 pmRNSDirector/PDMR Shareholding
4th Sep 20232:39 pmRNSDirector/PDMR Shareholding
24th Aug 20239:51 amRNSHolding(s) in Company
21st Aug 20237:00 amRNSTrading Update
1st Aug 202310:11 amRNSDirector/PDMR Shareholding
25th Jul 20239:45 amRNSHolding(s) in Company
21st Jul 20235:02 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSDirectorate Change
16th Jun 20238:56 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf-year Report
24th May 20231:38 pmRNSChange of Joint Corporate Broker
28th Apr 202311:45 amRNSChange of Registered Office
21st Apr 202311:35 amRNSHolding(s) in Company
17th Apr 20239:00 amRNSBlock listing Interim Review
13th Apr 20236:04 pmRNSHolding(s) in Company - Replacement
13th Apr 20239:36 amRNSHolding(s) in Company
6th Apr 20233:19 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:40 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.